Fundraising Fox
/Companies
Sign in

Orthobond

Monmouth Junction, US · Delaware corporation

Find your way into Orthobond

Sign up to see every warm intro you have to Orthobond

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Orthobond team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Orthobond develops proprietary antimicrobial nanosurface technology that covalently binds to metallic and polymeric surfaces to mechanically kill bacteria, viruses, and fungi without antibiotics or eluting chemicals. Its first products, including Ostaguard, are antimicrobial surface treatments for implantable medical devices, with intended future applications in textiles, consumer goods, and high-touch public surfaces.

HealthtechMedical DevicesNew Materials

Founders & leadership

DNDavid Nichols
David NicholsChief Executive OfficerHe has held senior leadership roles in medical device companies, with experience in product development, regulatory affairs, healthcare marketing, and reimbursement across spine and orthopedic technologies.
PG
Peter GoodwinNamed on SEC filing
FC
Frank CammisaNamed on SEC filing
KBKhalil Barrage
Khalil BarrageBoard Member
LD
Lisa D'UrsoNamed on SEC filing
DH
David HelfetNamed on SEC filing
PKPeter K. Scaturro
Peter K. ScaturroNon Executive Chairman/Vice Chairman/Board Member
GL
Gregory LutzNamed on SEC filing
PV
Paul VolovichNamed on SEC filing

Board

SMShailesh Maingi
Shailesh MaingiBoard of DirectorsShailesh Maingi is Founder and Managing Partner of Kineticos Life Sciences, a life-sciences private equity platform investing in therapeutics and enabling technologies across oncology, neurosciences, and antimicrobial resistance. He has over 25 years of experience across biopharma, CDMOs, and strategy, serves on multiple life-sciences company boards, previously advised and invested in Brammer Bio, and is a director at Orthobond.
APAnna Paulina Lutz
Anna Paulina LutzMember Board of DirectorsDirector at Orthobond, which develops antimicrobial nanosurface technology for implantable medical devices and other applications. She has experience building and leading remote cross-functional teams, with expertise in strategic planning and process improvement.
KG
Kenneth GallBoard director

Reported raises · per SEC filings

Form D private placements

$9.4M disclosed across 2 rounds · 2022–2026

▶$8.3MraisedSep 2026 · 24 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • David NicholsExecutive Officer, Director
  • Khalil BarrageDirector
  • Frank CammisaDirector
  • David HelfetDirector
  • Anna Paulina LutzDirector
  • Peter ScaturroDirector
  • Lisa D'UrsoDirector
  • Kenneth GallDirector
  • Shailesh MaingiDirector
  • Pritam MishraDirector
  • Eric MajorDirector
  • Greg ColeDirector
Offering amount
$10M
Amount sold
$8.3M
Minimum investment
$25K
Sales commissions
$475K
Placement agents
Lucid Capital Markets, Castle Hill Partners Inc.
First sale
Aug 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedSep 2022 · 8 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • David NicholsExecutive Officer, Director
  • Peter GoodwinDirector
  • Frank CammisaDirector
  • Khalil BarrageDirector
  • Lisa D'UrsoDirector
  • David HelfetDirector
  • Peter K. ScaturroDirector
  • Gregory LutzDirector
  • Paul VolovichExecutive Officer
Offering amount
$15M
Amount sold
$1.1M
Minimum investment
$50K
Sales commissions
$750K
Placement agents
Kola Agbaje
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

OrthoFiOrthoFi provides software and services for orthodontic and dental practices, covering patient onboarding, insurance verification and claims processing, patient financing, and accounts receivable collections. Its products, including AcceptCare and OrthoBanc, help practices increase case acceptance, offer flexible payment options to patients, and manage cash flow.
BrainlyBrainly provides 1:1 tutoring combining AI explanations with human expert intervention, targeting K-12 students and their parents seeking affordable academic support across all subjects. The platform emphasizes guaranteed grade improvement within 30 days, safety through human supervision of AI interactions, and compliance with education-focused privacy standards.

Companies working in the same space as Orthobond.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$146.4K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Orthobond do?
Orthobond develops proprietary antimicrobial nanosurface technology that covalently binds to metallic and polymeric surfaces to mechanically kill bacteria, viruses, and fungi without antibiotics or eluting chemicals. Its first products, including Ostaguard, are antimicrobial surface treatments for implantable medical devices, with intended future applications in textiles, consumer goods, and high-touch public surfaces.
How much funding has Orthobond raised?
Orthobond has disclosed $9.4M raised across 2 rounds.
Where is Orthobond headquartered?
Orthobond is headquartered in Monmouth Junction, US.